Skip to main content
Retour
Watch Compare

Baird Medical Investment Holdings Ltd

Qualité des données : 100%
Également cotée sous BDMDW NASDAQ
BDMD
NASDAQ Manufacturing Measuring & Analyzing Instruments
1,77 €
▼ 0,05 € (-2,75%)
Cap. Boursière: 67,94 M
Prix
1,85 €
Cap. Boursière
67,94 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

ROE of 3,12% is below average
Debt/Equity of 0,24 — conservative balance sheet
Negative free cash flow of -12,41 M
P/E of 54,84 — premium valuation
Capital efficient — spends only 6,44% of revenue on capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
3,12%
Au-dessus de la moyenne du secteur (-54,01%)
ROIC5,61%
Net Margin2,75%
Op. Margin10,81%

Sécurité

Debt / Equity
0,24
En dessous de la moyenne du secteur (0,30)
Current Ratio1,71
Interest Coverage5,69

Valorisation

PE (TTM)
54,84
Au-dessus de la moyenne du secteur (-1,49)
P/B Ratio1,91
EV/EBITDA11,57
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1385 pairs)
Métrique Action Médiane du Secteur
P/E 54,8 -1,5
P/B 1,9 1,6
ROE % 3,1 -54,0
Net Margin % 2,8 -41,5
Rev Growth 5Y % — 1,8
D/E 0,2 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 45,00 M Net Income (TTM) 1,24 M
ROE 3,12% ROA 1,59%
Gross Margin 87,09% Operating Margin 10,81%
Net Margin 2,75% Free Cash Flow (TTM) -12,41 M
ROIC 5,61% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,24 Current Ratio 1,71
Interest Coverage 5,69 Asset Turnover 0,58
Working Capital 25,28 M Tangible Book Value 35,52 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 54,84 Forward P/E N/A
P/B Ratio 1,91 P/S Ratio 1,51
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 11,57 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -18,26%
Market Cap 67,94 M Enterprise Value 76,35 M
Per Share
EPS (Diluted TTM) 0,06 Revenue / Share 1,23
FCF / Share -0,34 OCF / Share -0,26
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 6,44% FCF Conversion -1001,27%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024
Revenue 37,04 M
Net Income 12,60 M
EPS (Diluted) 0,49
Gross Profit 32,65 M
Operating Income 15,32 M
EBITDA —
R&D Expenses 6,17 M
SG&A Expenses —
D&A 1,14 M
Interest Expense 497 247,0
Income Tax 1,49 M

Balance Sheet

Annual, most recent first
Metric FY2024
Total Assets 77,96 M
Total Liabilities 38,20 M
Shareholders' Equity 39,66 M
Total Debt 4,45 M
Cash & Equivalents —
Current Assets 61,42 M
Current Liabilities 34,62 M